The verified answer
As of Oct 2026, DEPLOY verifies EndoQuest Robotics: 2 models, 6 deployments across 4 regions, $176.0M raised. 3 sources back the record.
CategorySurgical robots
Overview
Houston-based endoluminal robotic surgery company. CEO Eduardo Fonseca. Endoluminal Surgical (ELS) System — flexible robot for scar-free procedures through natural orifices.
PARADIGM Trial: FDA-approved final stage (Jan 2026), 50 patients, 5 US centers (Brigham, Mayo, Cleveland Clinic, AdventHealth, HCA). First robotic ESD by gastroenterologist in IDE trial (Oct 2025). Series D-2 co-led by Crescent Enterprises + Dr.
Fred Moll (Intuitive surgical co-founder). NVIDIA IGX Thor integration for AI vision. $176M total raised.
Verified record
- Verified deployments
- 6 deployments on file
- Active incidents
- None on file
Key facts
Product
Trial
FDA Status
Total Fundingsee investors →
Partnership
Data & sources
Web sources
3
3 sources backing this record.View all →
Models (2)
View all models →Current platform
Endoluminal Surgical (ELS) System
Endoluminal Surgical (ELS) System is a surgical robot from EndoQuest Robotics, currently in pilot deployment.
Current platform
Endoluminal Robotic Surgical System
Endoluminal Robotic Surgical System is a surgical robot from EndoQuest Robotics, currently in pilot deployment.
Partnerships
Every company EndoQuest Robotics has built with, alongside the ones only announced in a press release.
Most-frequent partners
- 1NVIDIA1× joint1115 total
Most recent
- EndoQuest Robotics x NVIDIA2026-01-12with NVIDIAjust announced
EndoQuest Robotics on the deployment map
View the global map6 verified deployments across 4 regions, newest verified Jan 2025. Explore where EndoQuest Robotics's robots are operating, by place and type.
- pilotEndoluminal Robotic Surgical System at Dallas-Houston Corridor, Texas, USA →Southwest · verified Jan 2025
- pilotEndoluminal Surgical (ELS) System at Orlando, Florida, USA →Southeast · verified Jan 2024
- pilotEndoluminal Surgical (ELS) System at Houston, Texas, USA →Southwest · verified Jan 2024
- pilotEndoluminal Surgical (ELS) System at Cleveland, Ohio, USA →Midwest · verified Jan 2024
- pilotEndoluminal Surgical (ELS) System at Mayo Clinic (Scottsdale) →Southwest · verified Jan 2024
- pilotEndoluminal Surgical (ELS) System at Boston, Massachusetts, USA →North America · verified Aug 2022
View the full EndoQuest Robotics deployment record →
Relationships
Current leadership (2)
- Eduardo Fonseca CEOreported, not verified
- Fred Moll Series D-2 Co-Lead Investorreported, not verified
Safety record
No incidents on record for EndoQuest Robotics.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Operator customers (1)
- EndoQuest Robotics6 deployments
Recent coverage
EndoQuest Robotics in third-party press
Peer companies
- DLR Institute of Robotics and Mechatronics6 models
- Brainlab2 models
- Intuitive Surgical2 models
- Koninklijke Philips2 models
- LEM Surgical2 models
- Neocis2 models
Mentioned on (7)
Registry pages whose text names EndoQuest Robotics.
Robots and products (2)
Endoluminal Robotic Surgical System, Endoluminal Surgical (ELS) System
Deployments (3)
Endoluminal Robotic Surgical System at Dallas-Houston Corridor, Texas, USA, Endoluminal Surgical (ELS) System at Boston, Massachusetts, USA, Endoluminal Surgical (ELS) System at Mayo Clinic (Scottsdale)
People (2)
Financial state
- Total funding
- $176.0M
- Reporting basis
- aggregator_estimate
- Lifecycle stage
- early
- Counterparty risk class
- unknown
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Partnerships
1 total · 1 just announced
Every company EndoQuest Robotics has built with, alongside the ones only announced in a press release.
Most recent
- EndoQuest Robotics x NVIDIA2026-01-12with NVIDIAjust announced
Most-frequent partners
- 1NVIDIA1× joint1115 total
Funding rounds (1)
- Series D-22025-07-16
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJul 22, 2026
Added to the verified registry
- Deployment verifiedVerifiedJan 1, 2025
Endoluminal Robotic Surgical System at Dallas-Houston Corridor, Texas, USA
- Deployment verifiedVerifiedJan 1, 2024
Endoluminal Surgical (ELS) System at Houston, Texas, USA
- Deployment verifiedVerifiedJan 1, 2024
Endoluminal Surgical (ELS) System at Orlando, Florida, USA
- Deployment verifiedVerifiedJan 1, 2024
Endoluminal Surgical (ELS) System at Mayo Clinic (Scottsdale)
Sources (3)
- https://www.massdevice.com/endoquest-gets-fda-green-light-to-initiate-final-stage-of-surgical-robot-trial/
- https://finance.yahoo.com/news/endoquest-robotics-secures-series-d-120000732.html
- https://www.businesswire.com/news/home/20260112765182/en/EndoQuest-to-Bring-AI-Powered-Vision-and-Precision-to-Endoluminal-Robotic-Surgery-with-NVIDIA-IGX-Thor
Common questions
What is EndoQuest Robotics?
What does EndoQuest Robotics make?
Is EndoQuest Robotics publicly traded?
Who competes with EndoQuest Robotics?
Who is the CEO of EndoQuest Robotics?
How can I invest in EndoQuest Robotics?
Where is EndoQuest Robotics headquartered?
How much funding has EndoQuest Robotics raised?
Who owns EndoQuest Robotics?
Where does EndoQuest Robotics operate robots?
How many robots has EndoQuest Robotics deployed?
Is EndoQuest Robotics a top robotics company?
Is EndoQuest Robotics safe?
Methodology: Verified · 3 sources (no primary) · last reviewed 2026-10-10
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-10-10
Sources by quality tier
- 3
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for EndoQuest Robotics.Peer companies
- DLR Institute of Robotics and Mechatronics6 models
- Brainlab2 models
- Intuitive Surgical2 models
- Koninklijke Philips2 models
- LEM Surgical2 models
- Neocis2 models
In the press
Recent coverage mentioning EndoQuest Robotics from third-party publications. Automatically surfaced; not part of the verified registry record.
EndoQuest Robotics completes enrollment in surgical robot trial
EndoQuest Robotics Announces Completion of Enrollment in the PARADIGM Trial
EndoQuest Advances Multicenter PARADIGM Trial with Completion of Procedures at Baylor St. Luke’s Medical Center
Sentante robot tech for treating stroke accepted into FDA TAP program
EndoQuest Earns FDA Approval for Last Stage of PARADIGM Trial
EndoQuest gets FDA green light to initiate final stage of surgical robot trial
EndoQuest Receives FDA Approval to Initiate Final Stage of PARADIGM Trial
EndoQuest to add AI-powered vision to surgical robot through Nvidia collab
EndoQuest to Bring AI-Powered Vision and Precision to Endoluminal Robotic Surgery with NVIDIA IGX Thor
EndoQuest taps NVIDIA for endoluminal robot advancement
EndoQuest to advance next-gen surgical robots with Nvidia AI
NVIDIA IGX Thor Robotics Processor Brings Real-Time Physical AI to the Industrial and Medical Edge
Machine-readable surfaces
- Markdown mirror: /companies/endoquest.md
- RSS feed: /companies/endoquest/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/06e82f4d-e2d5-4a09-a089-c752f2f22056
- Revision history: /companies/endoquest/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- DLR Institute of Robotics and Mechatronics6 models
- Brainlab2 models
- Intuitive Surgical2 models
- Koninklijke Philips2 models
- LEM Surgical2 models
- Neocis2 models
Video
Renowned Gi endoscopist Austin Chiang MD and robotics expert Steve Bell dive deeper into the merging worlds of endoluminal robotics and GI endoscopy. What are
What is the big news with endoluminal surgical robots in 2026. How is endoscopy about to change? Steve Bell gives his predictions on the big themes we will see.
Episode breakdown: 00:00 Introduction to Robotics and EndoQuest 02:55 The Problem of Traditional Endoscopy 06:13 Efficiency and Learning Curves in Endoscopic P
Kurt discusses the rapid development of the EndoQuest platform, which is a flexible endoluminal robotic surgery system with the ability to perform scar-free sur
Heat Index
Category contender77/100
A composite of competitive footprint, funding, press velocity, active partnerships, and supply-chain edges. Different from the Intelligence score below (which is per-form-factor productization). Non-robotics companies cap at 25.
Reality vs attention
EndoQuest Robotics draws attention at the 72nd percentile but verifies reality at the 77th percentile among surgical robots. Hype Gap -4.6, 27th widest among surgical robots.
6-month trend
Analysis
Clean safety record across 6 verified deployments. Limited public funding data for capital position assessment.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Oct 21, 2026